AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $950,000 | -66.8% | 500,000 | +181.6% | 0.20% | -47.8% |
Q2 2019 | $2,858,000 | -52.9% | 177,546 | -8.0% | 0.39% | -29.4% |
Q1 2019 | $6,074,000 | -8.9% | 192,994 | -4.9% | 0.55% | -26.2% |
Q4 2018 | $6,666,000 | -25.4% | 202,994 | -31.5% | 0.75% | -26.8% |
Q3 2018 | $8,935,000 | +89.5% | 296,251 | +68.3% | 1.03% | +57.8% |
Q2 2018 | $4,716,000 | – | 176,045 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |